• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本甲状旁腺外科医师协会对继发性和三发性甲状旁腺功能亢进症甲状旁腺切除术的评估。

Evaluation of Parathyroidectomy for Secondary and Tertiary Hyperparathyroidism by the Parathyroid Surgeons' Society of Japan.

作者信息

Tominaga Yoshihiro, Kakuta Takatoshi, Yasunaga Chikao, Nakamura Michio, Kadokura Yoshiyuki, Tahara Hideki

机构信息

Department of Transplant and Endocrine Surgery, Nagoya 2nd Red Cross Hospital, Nagoya, Japan.

Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Hachioji, Japan.

出版信息

Ther Apher Dial. 2016 Feb;20(1):6-11. doi: 10.1111/1744-9987.12352.

DOI:10.1111/1744-9987.12352
PMID:26879490
Abstract

Secondary hyperparathyroidism (SHPT) remains a serious complication in patients with chronic kidney disease, and some patients require parathyroidectomy. The Parathyroid Surgeons' Society of Japan (PSSJ) evaluated parathyroidectomy for SHPT and tertiary hyperparathyroidism (THPT) in Japan. The annual numbers of parathyroidectomies between 2004 and 2013 were evaluated using questionnaires. Since 2010, the PSSJ has registered the patients. In total, 826 patients from 42 institutions were registered. The annual number of parathyroidectomies for SHPT and THPT in Japan increased from 2004 to 2007 and then decreased markedly after 2007, with 296 operations performed in 2013. The number of women and men was almost equal (397/427). Median (interquartile range) age of these patients was 59.0 (24-87) years, the duration of hemodialysis before parathyroidectomy was 10.83 (0.0-38.7) years, and diabetic nephropathy was 87/826 (10.5%). Of these patients 59.6% were treated with cinacalcet at undergoing parathyroidectomy. In 75.3% of patients, a total parathyroidectomy with forearm autograft was performed. In 77.7% of patients, four or more parathyroid glands were removed during the initial operation. The incidences of husky voice and wound hemorrhage were 2.9% and 1.1%, respectively. The number of parathyroidectomies for SHPT in Japan decreased markedly after the introduction of cinacalcet. Based on the evaluation of registered patients, parathyroidectomies have been successfully performed at the institutions participating in the PSSJ.

摘要

继发性甲状旁腺功能亢进(SHPT)仍是慢性肾病患者的一种严重并发症,部分患者需要进行甲状旁腺切除术。日本甲状旁腺外科医师协会(PSSJ)对日本SHPT和三发性甲状旁腺功能亢进(THPT)的甲状旁腺切除术进行了评估。通过问卷调查评估了2004年至2013年间甲状旁腺切除术的年度数量。自2010年起,PSSJ开始对患者进行登记。共有来自42家机构的826例患者进行了登记。日本SHPT和THPT的甲状旁腺切除术年度数量在2004年至2007年增加,之后在2007年后显著下降,2013年进行了296例手术。女性和男性数量几乎相等(397/427)。这些患者的年龄中位数(四分位间距)为59.0(24 - 87)岁,甲状旁腺切除术前血液透析时间为10.83(0.0 - 38.7)年,糖尿病肾病患者为87/826(10.5%)。这些患者中59.6%在接受甲状旁腺切除术时接受了西那卡塞治疗。75.3%的患者进行了甲状旁腺全切术加前臂自体移植。77.7%的患者在初次手术时切除了四个或更多甲状旁腺。声音嘶哑和伤口出血的发生率分别为2.9%和1.1%。西那卡塞引入后,日本SHPT的甲状旁腺切除术数量显著下降。基于对登记患者的评估,参与PSSJ的机构已成功实施了甲状旁腺切除术。

相似文献

1
Evaluation of Parathyroidectomy for Secondary and Tertiary Hyperparathyroidism by the Parathyroid Surgeons' Society of Japan.日本甲状旁腺外科医师协会对继发性和三发性甲状旁腺功能亢进症甲状旁腺切除术的评估。
Ther Apher Dial. 2016 Feb;20(1):6-11. doi: 10.1111/1744-9987.12352.
2
Calcimimetics versus parathyroidectomy: What is preferable?拟钙剂与甲状旁腺切除术:哪种更可取?
Int Urol Nephrol. 2018 Jul;50(7):1271-1275. doi: 10.1007/s11255-018-1838-5. Epub 2018 Mar 12.
3
Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.慢性血液透析患者继发性甲状旁腺功能亢进治疗方法的近期变化及其与预后的关系:透析预后与实践模式研究(DOPPS)
Clin J Am Soc Nephrol. 2015 Jan 7;10(1):98-109. doi: 10.2215/CJN.12941213. Epub 2014 Dec 16.
4
Pharmaceutical Management of Secondary Hyperparathyroidism and the Role of Surgery: A 5-Year Retrospective Study.继发性甲状旁腺功能亢进的药物治疗及手术治疗的作用:一项 5 年回顾性研究。
Medicina (Kaunas). 2024 May 15;60(5):812. doi: 10.3390/medicina60050812.
5
Treatment of Secondary Hyperparathyroidism and Posttransplant Tertiary Hyperparathyroidism.继发性甲状旁腺功能亢进和移植后三发性甲状旁腺功能亢进的治疗。
J Surg Res. 2023 Nov;291:330-335. doi: 10.1016/j.jss.2023.06.031. Epub 2023 Jul 26.
6
Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis.继发性甲状旁腺功能亢进的慢性肾脏病患者甲状旁腺切除术后的长期死亡率:一项系统评价和荟萃分析。
Ren Fail. 2016 Aug;38(7):1050-8. doi: 10.1080/0886022X.2016.1184924. Epub 2016 May 19.
7
The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.西那卡塞在老年和年轻血液透析患者中的作用:盐酸西那卡塞治疗降低心血管事件的评估(EVOLVE)试验
Clin J Am Soc Nephrol. 2015 May 7;10(5):791-9. doi: 10.2215/CJN.07730814. Epub 2015 Feb 20.
8
The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial.西那卡塞对接受血液透析患者钙化性尿毒症小动脉病事件的影响:EVOLVE试验
Clin J Am Soc Nephrol. 2015 May 7;10(5):800-7. doi: 10.2215/CJN.10221014. Epub 2015 Apr 17.
9
Cinacalcet versus Parathyroidectomy in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation.西那卡塞与甲状旁腺切除术治疗肾移植术后继发性甲状旁腺功能亢进的比较
Rom J Intern Med. 2016 Sep 1;54(3):184-189. doi: 10.1515/rjim-2016-0027.
10
Etelcalcetide: injectable calcimimetic for the treatment of secondary hyperparathyroidism in hemodialysis-dependent patients.依特卡肽:用于治疗依赖血液透析患者继发性甲状旁腺功能亢进的注射用拟钙剂
Drugs Today (Barc). 2017 Sep;53(9):489-500. doi: 10.1358/dot.2017.53.9.2711938.

引用本文的文献

1
Outcome of subtotal parathyroidectomy for surgical treatment of hyperparathyroidism after renal transplantation.肾移植术后甲状旁腺次全切除术治疗甲状旁腺功能亢进症的手术疗效
Braz J Otorhinolaryngol. 2025 Jul;91 Suppl 1(Suppl 1):101623. doi: 10.1016/j.bjorl.2025.101623. Epub 2025 Jun 4.
2
Combination Treatment With Intravenous and Oral Calcimimetics for Secondary Hyperparathyroidism in Hemodialysis Patients Who Decline Parathyroidectomy.静脉注射与口服拟钙剂联合治疗拒绝甲状旁腺切除术的血液透析患者继发性甲状旁腺功能亢进
Cureus. 2025 Mar 30;17(3):e81474. doi: 10.7759/cureus.81474. eCollection 2025 Mar.
3
Parathyroid carcinoma in a dialysis patient definitively diagnosed after parathyroidectomy for uncontrolled secondary hyperparathyroidism.
一名透析患者在因无法控制的继发性甲状旁腺功能亢进接受甲状旁腺切除术后被确诊为甲状旁腺癌。
CEN Case Rep. 2025 Apr;14(2):167-170. doi: 10.1007/s13730-024-00924-9. Epub 2024 Aug 19.
4
Pre-Transplant Calcimimetic Use and Dose Information Improves the Accuracy of Prediction of Tertiary Hyperparathyroidism after Kidney Transplantation: A Retrospective Cohort Study.移植前使用拟钙剂和剂量信息可提高肾移植后甲状旁腺功能亢进症预测的准确性:一项回顾性队列研究。
Transpl Int. 2024 May 1;37:12704. doi: 10.3389/ti.2024.12704. eCollection 2024.
5
Treatment for secondary hyperparathyroidism focusing on parathyroidectomy.针对继发性甲状旁腺功能亢进症的治疗侧重于甲状旁腺切除术。
Front Endocrinol (Lausanne). 2023 Apr 20;14:1169793. doi: 10.3389/fendo.2023.1169793. eCollection 2023.
6
[Prediction model of recurrence after parathyroidectomy in secondary hyperparathyroidism].[继发性甲状旁腺功能亢进症甲状旁腺切除术后复发的预测模型]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Apr;37(4):282-287. doi: 10.13201/j.issn.2096-7993.2023.04.009.
7
Intraoperative intact parathyroid hormone monitoring and frozen section diagnosis are essential for successful parathyroidectomy in secondary hyperparathyroidism.术中甲状旁腺激素完整监测及冰冻切片诊断对于继发性甲状旁腺功能亢进症甲状旁腺切除术的成功至关重要。
Front Med (Lausanne). 2022 Nov 7;9:1007887. doi: 10.3389/fmed.2022.1007887. eCollection 2022.
8
Black patients are more likely to undergo parathyroidectomy for secondary hyperparathyroidism.黑人患者更有可能因继发性甲状旁腺功能亢进而接受甲状旁腺切除术。
Surgery. 2023 Jan;173(1):111-116. doi: 10.1016/j.surg.2022.05.040. Epub 2022 Oct 1.
9
A roadmap to parathyroidectomy for kidney transplant candidates.肾移植候选者甲状旁腺切除术路线图
Clin Kidney J. 2022 Feb 23;15(8):1459-1474. doi: 10.1093/ckj/sfac050. eCollection 2022 Aug.
10
Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemia.肾移植后一年甲状旁腺激素升高是移植肾丢失的独立危险因素,即使没有高钙血症也是如此。
BMC Nephrol. 2022 Jun 17;23(1):212. doi: 10.1186/s12882-022-02840-5.